Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Alberta

$682,394.00

Contribution of the cytoskeletal adaptor proteins paxillin and leupaxin to cytotoxic T cell migration and function

FY 2013-14

Summary
Our goal is to understand how killer cells or the "hit men" of the immune system find and kill virus infected cells or cancer cells within the body and eliminate them. We are trying to understand how killer cells move around to find infected cells and tumor cells, then once they find one, how they bind to it, deliver the lethal "hit" and then release from the dying cell to be free to find the next one to kill. We are studying the role of two related proteins, called paxillin and leupaxin, that are predicted to be important for allowing the killer cells to crawl around the body and bind to tumor cells. We have some evidence suggesting that paxillin is important for pointing the cellular lethal weapons towards the target cell to die. We propose to extend this to a model system to allow us to more fully dissect the contribution of paxillin to this process. Interestingly, tumor cells may use paxillin to help them move around the body during metastasis so our research may also provide insight into how cancer cells move to distant sites in the body.
Program
Operating Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
304242
Name
Ostergaard Hanne L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Contribution of the cytoskeletal adaptor proteins paxillin and leupaxin to cytotoxic T cell migration and function
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$682,394
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Adaptor Proteins; Adoptive Transfer; Cell Adhesion; Cell Migration; Confocal Microscopy; Cytolytic Activity; Cytotoxic T Lymphocyte; Flow Cytometry; Lymphocyte Activation; T Cell Differentiation
Abstract
Our goal is to understand how killer cells or the "hit men" of the immune system find and kill virus infected cells or cancer cells within the body and eliminate them. We are trying to understand how killer cells move around to find infected cells and tumor cells, then once they find one, how they bind to it, deliver the lethal "hit" and then release from the dying cell to be free to find the next one to kill. We are studying the role of two related proteins, called paxillin and leupaxin, that are predicted to be important for allowing the killer cells to crawl around the body and bind to tumor cells. We have some evidence suggesting that paxillin is important for pointing the cellular lethal weapons towards the target cell to die. We propose to extend this to a model system to allow us to more fully dissect the contribution of paxillin to this process. Interestingly, tumor cells may use paxillin to help them move around the body during metastasis so our research may also provide insight into how cancer cells move to distant sites in the body.
Competitiondate
201403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Ostergaard, Hanne L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $682,394~ $0~
University of Alberta - $682,394 Grant (2013-14) | Canada Spends